Printer Friendly

Nuvelo obtains United States patent.

Nuvelo, Inc. (Sunnyvale, CA) has patented polynucleotides isolated from cDNA libraries of human fetal liver-spleen and fetal liver as well as polypeptides encoded by these polynucleotides. The polypeptide is a human chemokine receptor that is a member of a family of G protein-coupled receptors characterized by seven transmembrane domains. Other aspects of the invention include vectors containing polynucleotides of the invention and related host cells as well a processes for producing chemokine receptor polypeptides, and antibodies specific for such polypeptides. (US 6,979,548)
COPYRIGHT 2005 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:for polynucleotides
Publication:BIOTECH Patent News
Article Type:Brief Article
Geographic Code:1USA
Date:Dec 1, 2005
Words:84
Previous Article:Bios Agriculture obtains United States patent.
Next Article:University of Pennsylvania obtains United States patent.
Topics:


Related Articles
Vical granted key DNA vaccine patent in Europe.
Vical patent for DNA vaccines Vaxfectin adjuvant.
Vical announces issuance of European patents covering platform technology.
Genset obtains United States patent.
Vical extends patent coverage for adjuvant to conventional vaccines.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters